Physician profile
Salah Amer
NPI 1689780926
$6,729.54
in general payments reported to CMS, 2019-2025
21 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $116 · 2021: $805 · 2022: $1,114 · 2023: $1,745 · 2024: $2,102 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,573.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,167.29 | 2019-2025 | Aveir, Gallant, Amplatzer Amulet |
| Boston Scientific Corporation | $662.28 | 2023-2025 | Watchman Flx, Emerge Push, Lux-Dx Insertable Cardiac Monitor |
| Heartflow, INC. | $442.58 | 2024-2025 | |
| Novo Nordisk INC | $377.81 | 2021-2025 | Ozempic |
| Edwards Lifesciences Corporation | $328.45 | 2024 | Sapien 3 Ultra Resilia |
| Kestra Medical Technology Services, INC. | $297.70 | 2022-2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $190.78 | 2021 | |
| Shockwave Medical, INC | $181.59 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Microport Crm USA INC | $156.28 | 2020-2021 | |
| Atricure, INC. | $139.14 | 2023 | |
| Impulse Dynamics (USA) INC. | $136.79 | 2022 | |
| Biosense Webster, INC. | $132.09 | 2025 | Carto 3, Nuvision Ice Catheter |
| Lexicon Pharmaceuticals, INC. | $121.81 | 2024 | Inpefa |
| Astrazeneca Pharmaceuticals LP | $101.65 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.29 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.16 | 2019 | |
| Biotronik INC. | $53.71 | 2025 | Biomonitor |
| E.R. Squibb & Sons, L.L.C. | $18.47 | 2025 | Camzyos |
| Pfizer INC. | $18.32 | 2020 | |
| Amarin Pharma, INC. | $17.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salah Amer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.